Compare ACET & YRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ACET | YRD |
|---|---|---|
| Founded | 1947 | 2012 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 83.3M | 88.4M |
| IPO Year | 2017 | 2015 |
| Metric | ACET | YRD |
|---|---|---|
| Price | $6.37 | $0.94 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $34.83 | N/A |
| AVG Volume (30 Days) | ★ 272.2K | 54.1K |
| Earning Date | 11-04-2026 | 09-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $427.64 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.86 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.46 | $0.82 |
| 52 Week High | $9.97 | $6.65 |
| Indicator | ACET | YRD |
|---|---|---|
| Relative Strength Index (RSI) | 34.28 | 39.05 |
| Support Level | N/A | $0.82 |
| Resistance Level | $8.85 | $1.05 |
| Average True Range (ATR) | 0.69 | 0.05 |
| MACD | -0.28 | 0.00 |
| Stochastic Oscillator | 3.45 | 21.43 |
Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for autoimmune diseases and cancer. It is advancing a pipeline of off-the-shelf gamma delta T cells, engineered with chimeric antigen receptors (CARs), to facilitate durable activity in patients. The company's main product candidate, prulacabtagene leucel (prula-cel), is an allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, and is being developed for the potential treatment of autoimmune diseases. Additionally, it is pursuing ADI-212, a next-generation gene-edited and armored clinical candidate designed to target prostate-specific membrane antigen (PSMA).
Yiren Digital Ltd is an AI-powered platform providing a comprehensive suite of financial and lifestyle services in China. Its mission is to elevate customers' financial well-being and enhance their quality of life by delivering digital financial services, tailor-made insurance solutions, and premium lifestyle services. The company supports clients at various growth stages, addressing financing needs arising from consumption and production activities, while aiming to augment the overall well-being and security of individuals, families, and businesses.